Brooktree Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$8.91M |
| 2 |
ExxonMobil
XOM
|
+$1.08M |
| 3 |
DexCom
DXCM
|
+$1.07M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.06M |
| 5 |
iShares US Technology ETF
IYW
|
+$1.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Angi Inc
ANGI
|
+$1.95M |
| 2 |
Interactive Brokers
IBKR
|
+$214K |
| 3 |
Apple
AAPL
|
+$198K |
| 4 |
Eli Lilly
LLY
|
+$169K |
| 5 |
Microsoft
MSFT
|
+$21.7K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 45.77% |
| 2 | Financials | 32.32% |
| 3 | Healthcare | 10.26% |
| 4 | Communication Services | 6.75% |
| 5 | Industrials | 1.59% |
Similar funds
Brooktree Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, Brooktree Capital Management held 43 positions worth $153M, up 15% from $133M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Brooktree Capital Management deployed $8.76M of net new capital in Q2 2025, opening 19 new positions and adding to 17 existing holdings. Its largest new stake was People Inc: 246,677 shares worth $9.21M.
By sector, the portfolio is most concentrated in Technology at 46% of assets, down from 50% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Interactive Brokers, an estimated $214K trimmed.
- Brooktree Capital Management's largest Q2 2025 buy was People Inc: 246,677 shares worth $9.21M.
- Brooktree Capital Management added most to DexCom in Q2 2025, an estimated $1.07M increase.
- Brooktree Capital Management's biggest Q2 2025 reduction was Interactive Brokers, cutting an estimated $214K.
- Brooktree Capital Management fully exited Angi Inc in Q2 2025, selling an estimated $1.95M.
- Brooktree Capital Management's ten largest holdings make up 80% of its $153M portfolio in Q2 2025.
- Brooktree Capital Management opened 19 new positions and closed 2 in Q2 2025.
- Brooktree Capital Management's portfolio value rose 15% quarter-over-quarter to $153M.
Based on Brooktree Capital Management's 13F filing for Q2 2025, filed 6 Aug 2025.